ArticleThe Pan African medical journal2024
[Prevalence and factors associated with hepatitis B and C among female sex workers in Bamako, Mali].
Article in The Pan African medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Knowledge and Attitudes of Women in the Pre- and Postnatal Period on Screening and Mother-to-Child Transmission of the Hepatitis B Virus in Mali.Journal of community health · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: hepatitis B (HBV) and C (HCV) are a public health problem, particularly in low- and middle-income countries. In Mali, West Africa, few data exist on the prevalence of these infections among vulnerable groups such as female sex workers (FSWs) living or not with the human immunodeficiency virus (HIV). This cross-sectional study conducted from March to October 2020 in Bamako, main city of Mali, among 400 FSWs (200 HIV+ and 200 HIV-) aimed to determine the prevalence and factors associated with HBs antigen on one hand and HCV antibodies on the other. Methods: a questionnaire was administered, and blood and vaginal samples were collected. Prevalences are presented according to HIV status and multivariate logistic regression was used to assess the determinants of HBV and HCV. Results: the prevalence of HBs antigen and HCV antibodies were 6.6% and 8.6% in HIV+ and 4.6% and 6.1% in HIV- women, respectively. In multivariate analyses, age at first paid sexual intercourse (< 18 years) and presence of HCV antibodies were strongly associated with HBV (adjusted odds ratio [aOR]; 95% Confidence interval [95%CI]: 3.3; 1.24-8.63 and 3.7; 1.21-11.54, respectively). Only HBs antigen was associated with HCV antibodies (aOR; 95%CI: 4.1; 1.29-12.56). Conclusion: in Mali, the relatively high frequency of viral hepatitis B and C among FSWs requires a targeted prevention program.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.